Shvedova Maria, Kobayashi Tatsuya
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Bone. 2020 Nov;140:115564. doi: 10.1016/j.bone.2020.115564. Epub 2020 Jul 31.
Small regulatory microRNAs (miRNAs) post-transcriptionally suppress gene expression. MiRNAs expressed in skeletal progenitor cells and chondrocytes regulate diverse aspects of cellular function and thus skeletal development. In this review, we discuss the role of miRNAs in skeletal development, particularly focusing on those whose physiological roles were revealed in vivo. Deregulation of miRNAs is found in multiple acquired diseases such as cancer; however congenital diseases caused by mutations in miRNA genes are very rare. Among those are mutations in miR-140 and miR-17~92 miRNAs which cause skeletal dysplasias. We also discuss pathological mechanisms underlining these skeletal dysplasias.
小型调节性微小RNA(miRNA)在转录后抑制基因表达。在骨骼祖细胞和软骨细胞中表达的miRNA调节细胞功能的多个方面,从而影响骨骼发育。在本综述中,我们讨论了miRNA在骨骼发育中的作用,特别关注那些在体内揭示了其生理作用的miRNA。在多种后天性疾病如癌症中发现了miRNA的失调;然而,由miRNA基因突变引起的先天性疾病非常罕见。其中包括导致骨骼发育异常的miR-140和miR-17~92 miRNA的突变。我们还讨论了这些骨骼发育异常背后的病理机制。